Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells-Reference-Cited by-同舟云学术

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells

Published:2017-01-13 Issue:8 Volume:8 Page:13652-13665
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Van Acker Heleen H.¹,Beretta Ottavio²,Anguille Sébastien¹³,Caluwé Lien De¹⁴,Papagna Angela²,Van den Bergh Johan M.¹,Willemen Yannick¹,Goossens Herman¹,Berneman Zwi N.¹³,Van Tendeloo Viggo F.¹,Smits Evelien L.¹³⁵,Foti Maria²,Lion Eva¹³

Affiliation:

1. Laboratory of Experimental Hematology, Tumor Immunology Group (TIGR), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

2. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

3. Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium

4. Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

5. Center for Oncological Research (CORE), University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities;Current Treatment Options in Oncology;2023-11-14

2. COMPARITIVE STUDY OF DENDRITIC CELL VACCINE PREPARATION WITH PRESENCE AND ABSENCE OF MALPIGHIA EMARGINATA FRUIT EXTRACT USING TUMOR RNA TRANSFECTION METHOD: A PROMISING APPROACH FOR PROSTATE CANCER;Asian Journal of Pharmaceutical and Clinical Research;2023-07-07

3. Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands;Frontiers in Immunology;2022-02-17

4. Research progress on dendritic cell vaccines in cancer immunotherapy;Experimental Hematology & Oncology;2022-01-24

5. GP96 and SMP30 Protein Priming of Dendritic Cell Vaccination Induces a More Potent CTL Response against Hepatoma;Journal of Healthcare Engineering;2022-01-07